{"id":"https://openalex.org/W2188404643","doi":null,"title":"New Trends in the Co-crystallization of Active Pharmaceutical Ingredients","display_name":"New Trends in the Co-crystallization of Active Pharmaceutical Ingredients","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2188404643","mag":"2188404643"},"language":"en","primary_location":{"id":"mag:2188404643","doi":null,"is_oa":false,"landing_page_url":"https://www.japsonline.com/admin/php/uploads/203_pdf.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074558681","display_name":"Veerendra K. Nanjwade","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Veerendra K. Nanjwade","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022639235","display_name":"F. V. Manvi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. V. Manvi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111801342","display_name":"Basavaraj K. Nanjwade","orcid":"https://orcid.org/0000-0001-7724-4415","observed_orcids":["https://orcid.org/0000-0001-7724-4415"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Basavaraj K. Nanjwade","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5059324550","display_name":"Meenaxi Maruti Maste","orcid":"https://orcid.org/0000-0002-1928-4483","observed_orcids":["https://orcid.org/0000-0002-1928-4483"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meenaxi M. Maste","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1928-4483","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2518,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.72463666,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10798","display_name":"Crystallography and molecular interactions","score":0.5170999765396118,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10798","display_name":"Crystallography and molecular interactions","score":0.5170999765396118,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.47049999237060547,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.007300000172108412,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cocrystals","display_name":"cocrystals","score":0.9390000104904175},{"id":"https://openalex.org/keywords/active-pharmaceutical-ingredients","display_name":"active pharmaceutical ingredients","score":0.9120000004768372},{"id":"https://openalex.org/keywords/co-crystallization","display_name":"co-crystallization","score":0.9269999861717224},{"id":"https://openalex.org/keywords/pharmaceutical-materials","display_name":"pharmaceutical materials","score":0.4729999899864197},{"id":"https://openalex.org/keywords/dissolution-enhancement","display_name":"dissolution enhancement","score":0.6499999761581421},{"id":"https://openalex.org/keywords/moisture-stability","display_name":"humidity stability","score":0.7120000123977661},{"id":"https://openalex.org/keywords/poorly-water-soluble-drugs","display_name":"poorly water-soluble drugs","score":0.8069999814033508},{"id":"https://openalex.org/keywords/hydrogen-bonding","display_name":"hydrogen bonding","score":0.6359999775886536},{"id":"https://openalex.org/keywords/pi-pi-stacking","display_name":"\u03c0-\u03c0 stacking","score":0.9440000057220459},{"id":"https://openalex.org/keywords/enantiomeric-separation","display_name":"enantiomer separation","score":0.6669999957084656},{"id":"https://openalex.org/keywords/pharmaceutical-formulations","display_name":"drug formulation","score":0.44200000166893005},{"id":"https://openalex.org/keywords/phase-transformation","display_name":"phase transformation","score":0.38600000739097595}],"concepts":[{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.7311161160469055},{"id":"https://openalex.org/C203036418","wikidata":"https://www.wikidata.org/wiki/Q284256","display_name":"Crystallization","level":2,"score":0.6796175837516785},{"id":"https://openalex.org/C126061179","wikidata":"https://www.wikidata.org/wiki/Q189627","display_name":"van der Waals force","level":3,"score":0.5841386318206787},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.5688085556030273},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.523182213306427},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.5217878818511963},{"id":"https://openalex.org/C5716244","wikidata":"https://www.wikidata.org/wiki/Q5191408","display_name":"Crystal engineering","level":4,"score":0.5095505714416504},{"id":"https://openalex.org/C93275456","wikidata":"https://www.wikidata.org/wiki/Q756449","display_name":"Supramolecular chemistry","level":3,"score":0.48342835903167725},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.48132598400115967},{"id":"https://openalex.org/C2781285689","wikidata":"https://www.wikidata.org/wiki/Q21921428","display_name":"Crystal (programming language)","level":2,"score":0.4393167197704315},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3745886981487274},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.3557193875312805},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.3506050705909729},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.27496883273124695},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.19555717706680298},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.07904747128486633},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2188404643","doi":null,"is_oa":false,"landing_page_url":"https://www.japsonline.com/admin/php/uploads/203_pdf.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1617054779","https://openalex.org/W1988446020","https://openalex.org/W1997077098","https://openalex.org/W1998552907","https://openalex.org/W1998920258","https://openalex.org/W2000654791","https://openalex.org/W2005574399","https://openalex.org/W2013027128","https://openalex.org/W2018934996","https://openalex.org/W2019463239","https://openalex.org/W2022087123","https://openalex.org/W2023446564","https://openalex.org/W2024071582","https://openalex.org/W2036396946","https://openalex.org/W2050586289","https://openalex.org/W2065172707","https://openalex.org/W2067129640","https://openalex.org/W2069032040","https://openalex.org/W2072432140","https://openalex.org/W2079268284","https://openalex.org/W2081078311","https://openalex.org/W2142472136","https://openalex.org/W2328298168","https://openalex.org/W2952528349"],"related_works":["https://openalex.org/W2188939820","https://openalex.org/W115874281","https://openalex.org/W2131653053","https://openalex.org/W2185858535","https://openalex.org/W2188959189","https://openalex.org/W3007949604","https://openalex.org/W7085723467","https://openalex.org/W2954099136","https://openalex.org/W2182420261","https://openalex.org/W7096919732"],"abstract_inverted_index":{"Pharmaceutical":[0,87,152],"materials":[1,31,56],"science":[2],"being":[3],"a":[4,50,78,82,163],"fundamental":[5],"branch":[6],"that":[7],"continuously":[8],"provides":[9],"important":[10],"insights,":[11],"theories,":[12],"and":[13,65,77,93,106,132,172,227],"technologies":[14],"to":[15,28,53,97,150,157,196,211],"formulation":[16,171],"sciences.":[17],"The":[18],"recent":[19],"advances":[20],"in":[21,108,166],"this":[22],"area":[23],"have":[24],"brought":[25],"the":[26,36,113,117,143,167,192,201,205,213],"possibility":[27],"produce":[29],"pharmaceutical":[30,55,109,188,217],"by":[32],"design.":[33],"In":[34,199],"particular,":[35],"formation":[37],"of":[38,44,60,69,75,81,116,126,145,147,169,187,216,223,230],"co-crystals,":[39],"i.e.":[40],"crystalline":[41,148],"molecular":[42],"complexes":[43,92],"twoor":[45],"more":[46],"neutral":[47],"molecules,":[48],"represents":[49],"potential":[51],"route":[52],"achieve":[54],"with":[57],"improved":[58],"properties":[59,160,215],"interest,":[61],"including":[62,128],"dissolution":[63,221],"rate":[64,222],"stability":[66,105,229],"under":[67],"conditions":[68],"high":[70],"relative":[71],"humidity.":[72],"Co-crystals":[73],"consists":[74],"API":[76,170],"stoichiometric":[79],"amount":[80],"pharmaceutically":[83],"acceptable":[84],"co-crystal":[85,206],"former.":[86],"co-crystals":[88,153,182],"are":[89],"nonionic":[90],"supramolecular":[91],"can":[94,120,173,208],"be":[95,121,174,209],"used":[96],"address":[98],"physical":[99,228],"property":[100],"issues":[101],"such":[102,219],"as":[103,183,220],"solubility,":[104],"bioavailability":[107],"development":[110],"without":[111],"changing":[112],"chemical":[114],"composition":[115],"API.":[118],"These":[119],"constructed":[122],"through":[123],"several":[124],"types":[125],"interaction,":[127],"hydrogen":[129],"bonding,":[130],"pi-stacking,":[131],"van":[133],"der":[134],"Waals":[135],"forces.":[136],"Phase":[137],"transformations":[138],"induced":[139],"during":[140],"processing/storage":[141],"affects":[142],"mechanisms":[144],"conversion":[146],"drugs":[149],"co-crystals.":[151],"considered":[154],"better":[155],"alternatives":[156],"optimize":[158],"drug":[159],"could":[161],"play":[162],"major":[164],"part":[165],"future":[168],"employed":[175],"for":[176],"chiral":[177],"resolution.":[178],"This":[179],"review":[180],"introduces":[181],"an":[184],"emerging":[185],"class":[186],"materials,":[189],"focusing":[190],"on":[191],"experimental":[193],"methods":[194],"applicable":[195],"their":[197],"crystallization.":[198],"addition,":[200],"examples":[202],"illustrating":[203],"how":[204],"approach":[207],"utilized":[210],"enhance":[212],"specific":[214],"solids,":[218],"poorly-water":[224],"soluble":[225],"APIs":[226],"moisture-labile":[231],"APIs.":[232]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2016-06-24T00:00:00"}